Home Life Sciences Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
Article Open Access

Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis

  • Panli Tian , Yanli Ma and Tao Shang EMAIL logo
Published/Copyright: November 20, 2025

Abstract

Src homology phosphotyrosyl phosphatase 2 (SHP-2) has been implicated in the pathogenesis of diabetic nephropathy (DN), while pyroptosis, an inflammatory form of programmed cell death, has also been associated with disease progression. However, the regulatory interplay between SHP-2 and pyroptosis in DN remains incompletely understood. In this study, we established DN rat models using a single intraperitoneal injection of streptozotocin (STZ) and HK-2 cells cultured under high-glucose (HG) conditions. Hematoxylin and eosin staining was performed to assess the histopathological changes in renal tissues, while immunofluorescence and Western blotting were used to evaluate SHP-2 and NLRP3 expression in both rat kidney tissues and HK-2 cells. Lentiviral transfection was performed to overexpress SHP-2 or NLRP3, following which the expression of pyroptosis-related proteins, activation of the NLRP3 inflammasome, and cell apoptosis were assessed by Western blot and flow cytometry. The results demonstrated that STZ-treated rats exhibited significant weight loss, hyperglycemia, and renal tissue injury. We observed an increase in SHP-2 expression in the kidney tissues of DN rats and in HK-2 cells exposed to high glucose, along with an elevated expression of NLRP3. SHP-2 knockdown suppressed NLRP3 inflammasome activation and mitigated HG-induced pyroptosis in renal tubular epithelial cells. Notably, overexpression of NLRP3 partially reversed the protective effects conferred by SHP-2 knockdown. These findings suggest that SHP-2 knockdown alleviates renal tubular epithelial cell injury in DN by inhibiting NLRP3 inflammasome-mediated pyroptosis.

Graphic abstract

1 Introduction

Diabetes mellitus (DM) is a complex metabolic disorder characterized by dysregulated energy metabolism. Its complications, including diabetic neuropathy (DN), cardiovascular disease, severely impair patients’ quality of life and remain difficult to manage clinically [1]. Among these, DN is a leading cause of chronic kidney disease and end-stage renal disease, and significantly contributes to the high disability and mortality rates associated with DM [2]. Thus, understanding the pathogenic mechanisms underlying DN is therefore essential for the development of effective therapeutic strategies. It is well established that immune and inflammatory responses play a central role in the onset and progression of DN, particularly in the context of renal tubular injury [3]. Pyroptosis, a form of programmed cell death driven by inflammatory signaling, has been increasingly recognized in this process. In particular, NLRP3 inflammasome-mediated pyroptosis has been shown to contribute to DN pathogenesis [4].

Src homology phosphotyrosyl phosphatase 2 (SHP-2), encoded by the PTPN11 gene, belongs to the non-receptor tyrosine phosphatase family and is essential for maintaining cellular function [5]. SHP-2 is involved in the regulation of inflammatory responses, cell survival, and metabolic homeostasis, among other processes [6]. In a high-glucose (HG) environment, elevated uric acid may activate the ROS/NLRP3/SHP-2 signaling pathway, thereby promoting epithelial–mesenchymal transition in renal tubular epithelial cells and accelerating the development of renal fibrosis in DN [7]. Similarly, in sepsis-associated encephalopathy, Nogo-A has been shown to exacerbate disease progression by disrupting the SHP-2/NLRP3 balance in microglia through reactive oxygen species (ROS) generation and M1 polarization [8]. In renal carcinoma, allosteric inhibition of SHP-2 has been found to induce caspase-1-dependent pyroptosis to enhance interferon-α-mediated antitumor immunity [9].

Despite these findings, the role and underlying mechanisms of SHP-2 in renal tubular injury in DN remain poorly defined. To address this gap, the present study aimed to investigate the functional role of SHP-2 in tubular epithelial injury in DN using an in vitro model, with the goal of elucidating potential molecular pathways involved.

2 Methods

2.1 Animal experimental design

All animal procedures were approved by the Laboratory Animal Ethics Committee (Changsha, China) and were conducted in accordance with internationally accepted ethical guidelines. Briefly, male C57BL/6 mice aged 8 weeks were randomly assigned to two groups: a streptozotocin (STZ) group and a control group (n = 6 per group). Both groups were housed under identical conditions for 12 weeks. To induce DN, mice in the STZ group received a single intraperitoneal injection of STZ at a dose of 60 mg/kg [10]. Blood glucose levels were monitored via tail vein sampling. Mice with blood glucose levels exceeding 16.7 mM for three consecutive days were considered to have successfully developed DN.

  1. Ethical approval: The research related to animal use has been complied with all the relevant national regulations and institutional policies for the care and use of animals, and has been approved by the Ethics Committee of People’s Hospital of Ningxia Hui Autonomous Region (Approval no. 2023-NZR-063).

2.2 Hematoxylin and eosin (H&E) staining

Kidney tissues were fixed overnight in 4% paraformaldehyde (pH 7.4), embedded in paraffin, and sectioned into 5 μm serial slices. These sections were stained with H&E to assess histopathological changes. Morphological alterations in the glomeruli and tubulointerstitium were observed under a fluorescence microscope (Olympus, Nanjing).

2.3 Immunofluorescence

Fixed tissues were permeabilized with PBS containing 0.5% Triton X-100. After blocking with 3% bovine serum albumin for 1 h, the tissues were incubated overnight at 4°C with primary antibodies against SHP-2 (1:100, ab300579, Abcam) and NLRP3 (1:200, ab263899, Abcam). The next day, the tissues were incubated for 1 h at room temperature in the dark with a fluorescently labeled secondary antibody (Alexa Fluor® 488; ab150077, Abcam), the nuclei were counterstained with DAPI for 10 min, and fluorescence signals were visualized using a fluorescence microscope.

2.4 Cell culture and treatment

Human renal proximal tubular epithelial cells (HK-2) (ATCC, USA) were cultured in DMEM/F12 medium (Gibco) supplemented with 10% fetal bovine serum and antibiotics, in a humidified incubator at 37°C with 5% CO2. When cells reached approximately 80% confluence, they were treated with HG (30 mM) and divided into four groups: (A) Control, (B) HG group, (C) HG + shNC group, and (D) HG + shSHP-2 group.

2.5 Transfection experiments

The short hairpin RNA (shRNA) targeting SHP-2 (sequence: 5′-GGGCCAGAGCAGTCAGTAA-3′) was obtained from Shanghai Gene Pharmaceutical Co., Ltd. HK-2 cells were transfected using Lipofectamine® 3000 reagent (Invitrogen, USA), with a scrambled shRNA (shNC) used as the negative control. After transfection, the cells were exposed to 30 mM D-glucose for 24 h, and in a separate experiment, SHP-2–silenced HK-2 cells (shSHP-2) were transfected with the pcDNA3.1-NLRP3 overexpression vector (oe-NLRP3) using the same reagent. Overall, the transfection period for all groups was 48 h.

2.6 Flow cytometry

Flow cytometric analysis was performed to evaluate programmed cell death using an Annexin V-FITC/PI apoptosis detection kit (Beyotime). Adherent cells were collected and stained in the dark with 5 µL Annexin V-FITC and 10 µL propidium iodide. The samples were then analyzed using a CytoFLEX flow cytometer (Beckman Coulter, USA), and the results were assessed using the CytExpert 2.1 software (Beckman Coulter, USA).

2.7 Western blotting

Total proteins were extracted from HK-2 cells using RIPA lysis buffer (Beyotime). Protein concentrations were determined using a BCA protein assay kit (Beyotime). Equal amounts of protein were separated by SDS-PAGE and transferred onto PVDF membranes (Millipore, MA, USA), the membranes were blocked with 5% skim milk for 2 h at room temperature and then incubated overnight at 4°C with the following primary antibodies: SHP-2 (ab300579), NLRP3 (ab263899), ASC (ab309497), pro-caspase-1 (ab179515), IL-1β (ab283818), GSDMD (ab219800), and GAPDH (ab9485), all from Abcam. After washing, the membranes were incubated with appropriate secondary antibodies (Proteintech, Wuhan, China) for 1 h at room temperature. Immunoreactive bands were visualized using enhanced chemiluminescence reagents (Millipore, MA, USA).

2.8 Statistical analysis

Statistical analyses were performed using SPSS version 20.0 (IBM Corp., Armonk, NY, USA). Data are presented as mean value ± standard deviation (SD). Differences among multiple groups were assessed using one-way analysis of variance, and comparisons between two groups were conducted using Student’s t-test. A P-value <0.05 was considered to indicate statistical significance.

3 Results

3.1 SHP-2 is highly expressed in the kidney tissue of diabetic mice

After STZ injection, the mice exhibited a significant reduction in body weight along with a marked elevation in blood glucose levels, confirming the successful establishment of the diabetic mouse model (Figure 1a). H&E staining further validated the DN model, revealing disappearance of the proximal renal tubular brush border and the presence of vacuolar degeneration in the kidneys of STZ-treated mice compared to the control group (Figure 1b). Immunofluorescence analysis demonstrated increased expression of SHP-2 and NLRP3 in the renal tissues of STZ-treated mice (Figure 1c), indicating that both proteins may be involved in renal tubular injury associated with DN.

Figure 1 
                  SHP-2 is highly expressed in the kidney tissue of diabetic mice. (a) Body weight and blood glucose levels in mice. (b) H&E staining of kidney tissues to assess pathological changes. (c) Immunofluorescence analysis of SHP-2 and NLRP3 expression in kidney tissue. Values are presented as mean value ± SD. ***p < 0.001 vs Control. n = 6.
Figure 1

SHP-2 is highly expressed in the kidney tissue of diabetic mice. (a) Body weight and blood glucose levels in mice. (b) H&E staining of kidney tissues to assess pathological changes. (c) Immunofluorescence analysis of SHP-2 and NLRP3 expression in kidney tissue. Values are presented as mean value ± SD. ***p < 0.001 vs Control. n = 6.

3.2 SHP-2 expression is elevated in HK2 cells treated with high glucose

To further investigate the role of SHP-2 in DN, we utilized HG treatment to simulate diabetic conditions in HK-2 cells. Consistent with the in vivo findings, HG exposure led to elevated expression of SHP-2 and NLRP3 in HK-2 cells (Figure 2), suggesting a potential involvement of SHP-2 in HG-induced renal tubular epithelial cell injury.

Figure 2 
                  SHP-2 expression is elevated in HK-2 cells treated with high glucose. Expression of SHP-2 and NLRP3 in HK-2 cells following HG treatment. Values are presented as mean value ± SD. ***p < 0.001 vs Control. n = 3.
Figure 2

SHP-2 expression is elevated in HK-2 cells treated with high glucose. Expression of SHP-2 and NLRP3 in HK-2 cells following HG treatment. Values are presented as mean value ± SD. ***p < 0.001 vs Control. n = 3.

3.3 Knockdown of SHP-2 inhibits pyroptosis in HK2 cells treated with high glucose

Given the known regulatory role of SHP-2 in pyroptosis under various physiological and pathological conditions, we examined its function in HG-induced pyroptosis in HK-2 cells. The results indicated that SHP-2 knockdown effectively reduced SHP-2 expression under HG conditions (Figure 3a). Notably, the HG-induced upregulation of caspase-1, GSDMD, IL-1β, and inflammasome components, including NLRP3, ASC, and pro-caspase-1, was significantly attenuated after SHP-2 silencing (Figure 3a). In addition, SHP-2 knockdown significantly reduced HG-induced apoptosis in HK-2 cells (Figure 3b). These results indicate that SHP-2 promotes HG-induced pyroptosis and apoptosis in renal tubular epithelial cells.

Figure 3 
                  Knockdown of SHP-2 inhibits pyroptosis in HK-2 cells treated with high glucose. (a) Western blot analysis of SHP-2, NLRP3, ASC, pro-caspase-1, caspase-1, IL-1β, and GSDMD expression. (b) Flow cytometric analysis of apoptosis rate. Values are presented as mean value ± SD. ***p < 0.001 vs Control. ##
                     p < 0.01, ###
                     p < 0.001 vs HG + shNC. n = 3.
Figure 3

Knockdown of SHP-2 inhibits pyroptosis in HK-2 cells treated with high glucose. (a) Western blot analysis of SHP-2, NLRP3, ASC, pro-caspase-1, caspase-1, IL-1β, and GSDMD expression. (b) Flow cytometric analysis of apoptosis rate. Values are presented as mean value ± SD. ***p < 0.001 vs Control. ## p < 0.01, ### p < 0.001 vs HG + shNC. n = 3.

3.4 Activation of NLRP3 reverses the effects of overexpressed SHP-2

To determine whether NLRP3 mediates the pro-pyroptotic effects of SHP-2, we overexpressed NLRP3 in SHP-2-silenced HK-2 cells. Western blot analysis confirmed successful overexpression of NLRP3. Compared with SHP-2 knockdown alone, NLRP3 overexpression restored the expression of pro-caspase-1, IL-1β, ASC, and GSDMD and partially inhibited the anti-apoptotic effects observed in SHP-2–silenced cells (Figure 4). Collectively, these findings suggest that knockdown of SHP-2 suppresses the activation of the NLRP3 inflammasome, thereby attenuating HG-induced pyroptosis in renal tubular epithelial cells, while NLRP3 overexpression can partially reverse this protective effect.

Figure 4 
                  Activation of NLRP3 reverses the effects of SHP-2 knockdown. (a) Western blot analysis of NLRP3, ASC, caspase-1, IL-1β, and GSDMD expression. (b) Flow cytometric analysis of apoptosis rate. Values are presented as mean value ± SD. ***p < 0.001 vs Control. ###
                     p < 0.001 vs HG + shNC. ^^^
                     p < 0.001 vs HG + shSHP-2. n = 3.
Figure 4

Activation of NLRP3 reverses the effects of SHP-2 knockdown. (a) Western blot analysis of NLRP3, ASC, caspase-1, IL-1β, and GSDMD expression. (b) Flow cytometric analysis of apoptosis rate. Values are presented as mean value ± SD. ***p < 0.001 vs Control. ### p < 0.001 vs HG + shNC. ^^^ p < 0.001 vs HG + shSHP-2. n = 3.

4 Discussion

DN is one of the leading causes of chronic renal failure, and its pathogenesis involves multiple contributing factors. Despite ongoing research, the underlying pathophysiological mechanisms of DN remain incompletely elucidated [11]. Pyroptosis, a recently recognized form of programmed cell death distinct from necrosis and apoptosis, has been implicated in the development and progression of diabetes and its complications, including DN [4,12].

Given the emerging role of SHP-2 in renal pathophysiology, we investigated its involvement in pyroptosis in the context of DN, as the regulatory mechanisms underlying pyroptosis in this setting are not yet fully defined. Previous studies have demonstrated that SHP-2 is upregulated in diabetic kidneys and contributes to renal inflammation in diabetic rats [13]. Moreover, macrophage-specific SHP-2 deficiency has been shown to attenuate DN by suppressing inflammation mediated through the MAPK and NF-κB pathways [14], further supporting the association between SHP-2 and DN pathogenesis. Additionally, inhibition of the SHP-2/PI3K/NLRP3 axis has been reported to reduce pyroptosis and ameliorate non-alcoholic steatohepatitis [15], while SHP-2 has also been implicated in promoting pyroptosis and activating the NLRP3 inflammasome in renal cell carcinoma [9]. However, the relationship between SHP-2 and pyroptosis in renal tubular epithelial cells under diabetic conditions had not been previously established. In this present study, we found that SHP-2 expression was upregulated in DN mice kidney tissues and HG-treated HK-2 cells, consistent with earlier reports. Importantly, SHP-2 knockdown significantly reduced HG-induced pyroptosis in renal tubular epithelial cells, suggesting that SHP-2 overexpression may serve as a key initiator of pyroptosis in DN.

Pyroptosis is a distinct form of inflammatory cell death mediated by caspase-1 and regulated via the GSDMD signaling cascade [16]. It is typically initiated by inflammasome activation, with the NLRP3 inflammasome playing a central role in the inflammatory response and pyroptotic cell death [17]. GSDMD is the primary executioner of pyroptosis; upon inflammasome activation, it is cleaved by caspase-1 or caspase-11 to release the N-terminal fragment (GSDMD-N), and this active fragment binds to phospholipids in the cell membrane, forming pores that lead to cell swelling and lysis, leading to the disruption of membrane integrity, the release of inflammatory mediators, and cell death in response to microbial invasion or endogenous danger signals [18].

Although our studies demonstrate that SHP-2 knockdown alleviates pyroptosis by inhibiting the NLRP3 inflammasome, the upstream mechanisms regulating SHP-2 expression in DN remain to be fully elucidated. Previous studies have shown that SHP-2 is regulated by multiple factors under diabetic conditions. For example, previous studies have shown that SHP-2 is regulated by multiple factors under diabetic conditions. For example, ROS have been shown to activate SHP-2 through oxidative modification or activation of upstream kinases [19]. Furthermore, in the local inflammatory microenvironment of DN, inflammatory cell infiltration leads to increased profibrotic cytokine pressure, which may partly explain the activation of SHP-2 in DN [13]. Future studies aiming to identify the precise upstream regulators of SHP-2 in renal tubular cells will further enhance our understanding of its role in the pathogenesis of DN and may provide new therapeutic targets.

Our findings further demonstrated that NLRP3 overexpression partially reversed the inhibitory effects of SHP-2 knockdown on pyroptosis in HG-treated HK-2 cells, indicating that SHP-2 induces pyroptosis of renal tubular epithelial cells through NLRP3.

5 Conclusion

In summary, our findings indicate that SHP-2 expression is increased in both DN mice and HK-2 cells treated with HG, and its knockdown reduced HG-induced pyroptosis in HK-2 cells, an effect that appeared to be partly mediated by the NLRP3 pathway, which could then prevent the progression of DN.


tel: +86-15809681413

  1. Funding information: This work was supported by Ningxia Natural Science Foundation (Grant No. 2024AAC03468).

  2. Author contributions: Panli Tian, Yanli Ma, and Tao Shang designed the study, carried them out, supervised the data collection, analyzed the data, interpreted the data, prepare the manuscript for publication, and reviewed the draft of the manuscript. All authors have read and approved the manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Wang Y, Wu H, Deng R, Dai XJ, Bu YH, Sun MH, et al. Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro. Phytother Res. 2021;35(8):4347–62.10.1002/ptr.7130Search in Google Scholar PubMed

[2] Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107(4):689–705.10.1016/j.mcna.2023.03.004Search in Google Scholar PubMed

[3] Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fernandez C, Marchant V, Donate-Correa J, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2023;103(2):282–96.10.1016/j.kint.2022.10.030Search in Google Scholar PubMed

[4] Al Mamun A, Ara Mimi A, Wu Y, Zaeem M, Abdul Aziz M, Aktar Suchi S, et al. Pyroptosis in diabetic nephropathy. Clin Chim Acta. 2021;523:131–43.10.1016/j.cca.2021.09.003Search in Google Scholar PubMed

[5] Yu D, Zheng M, Liu Y, Chen L, Li H. Proteolysis-targeting chimera molecules targeting SHP2. Future Med Chem. 2022;14(8):587–600.10.4155/fmc-2021-0324Search in Google Scholar PubMed

[6] Stefanski AL, Renecle MD, Kramer A, Sehgal S, Narasimhan P, Rumer KK, et al. Siglec-6 signaling uses Src kinase tyrosine phosphorylation and SHP-2 recruitment. Cells. 2022;11(21):3427.10.3390/cells11213427Search in Google Scholar PubMed PubMed Central

[7] Tian L, Yu Q, Zhang L, Zhang J. Accelerated fibrosis progression of diabetic nephropathy from high uric acid’s activation of the ROS/NLRP3/SHP2 pathway in renal tubular epithelial cells under high glucose conditions. Altern Ther Health Med. 2025;31(5):162–9.Search in Google Scholar

[8] Liu Y, Guo L, Zhang G, Sun W, Yang X, Liu Y. Nogo-A exacerbates sepsis-associated encephalopathy by modulating microglial SHP-2/NLRP3 balance and inducing ROS and M1 polarization. Biomol Biomed. 2024;25(1):210–25.10.17305/bb.2024.10822Search in Google Scholar PubMed PubMed Central

[9] Xi R, Cao Y, Fu N, Sheng Y, Yu J, Li L, et al. Allosteric inhibition of the tyrosine phosphatase SHP2 enhances the anti-tumor immunity of interferon alpha through induction of caspase-1-mediated pyroptosis in renal cancer. Int Immunopharmacol. 2024;143(Pt 2):113498.10.1016/j.intimp.2024.113498Search in Google Scholar PubMed

[10] Zhao W, He C, Jiang J, Zhao Z, Yuan H, Wang F, et al. The role of discoid domain receptor 1 on renal tubular epithelial pyroptosis in diabetic nephropathy. Korean J Physiol Pharmacol. 2022;26(6):427–38.10.4196/kjpp.2022.26.6.427Search in Google Scholar PubMed PubMed Central

[11] Samsu N. Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449.10.1155/2021/1497449Search in Google Scholar PubMed PubMed Central

[12] Cao Z, Huang D, Tang C, Lu Y, Huang S, Peng C, et al. Pyroptosis in diabetes and diabetic nephropathy. Clin Chim Acta. 2022;531:188–96.10.1016/j.cca.2022.04.011Search in Google Scholar PubMed

[13] Yu C, Li Z, Nie C, Chang L, Jiang T. Targeting Src homology phosphatase 2 ameliorates mouse diabetic nephropathy by attenuating ERK/NF-kappaB pathway-mediated renal inflammation. Cell Commun Signal. 2023;21(1):362.10.1186/s12964-023-01394-9Search in Google Scholar PubMed PubMed Central

[14] Han X, Wei J, Zheng R, Tu Y, Wang M, Chen L, et al. Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-kappaB-Dependent Inflammation. Diabetes. 2024;73(5):780–96.10.2337/db23-0700Search in Google Scholar PubMed

[15] Yuan X, Yang L, Gao T, Gao J, Wang B, Liu C, et al. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway. Front Pharmacol. 2024;15:1423903.10.3389/fphar.2024.1423903Search in Google Scholar PubMed PubMed Central

[16] Vasudevan SO, Behl B, Rathinam VA. Pyroptosis-induced inflammation and tissue damage. Semin Immunol. 2023;69:101781.10.1016/j.smim.2023.101781Search in Google Scholar PubMed PubMed Central

[17] Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43(8):653–68.10.1016/j.tips.2022.04.003Search in Google Scholar PubMed

[18] Kovacs SB, Miao EA. Gasdermins: Effectors of pyroptosis. Trends Cell Biol. 2017;27(9):673–84.10.1016/j.tcb.2017.05.005Search in Google Scholar PubMed PubMed Central

[19] Zhang J, Liu X, Liu J. PHPS1 enhances PD-L1 serine phosphorylation by regulating ROS/SHP-2/AMPK activity to promote apoptosis of oral squamous cell carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao. 2024;44(12):2469–76.Search in Google Scholar

Received: 2025-04-16
Revised: 2025-09-08
Accepted: 2025-09-08
Published Online: 2025-11-20

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
  3. Maslinic acid improves mitochondrial function and inhibits oxidative stress and autophagy in human gastric smooth muscle cells
  4. Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT
  5. Post-pandemic insights on COVID-19 and premature ovarian insufficiency
  6. Proteome differences of dental stem cells between permanent and deciduous teeth by data-independent acquisition proteomics
  7. Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification
  8. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
  9. Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant Staphylococcus and Streptococcus pathogens of acne origins
  10. Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–B-escin conjugates as SARS-CoV-2 inhibitors
  11. Neurodegenerative diseases and neuroinflammation-induced apoptosis
  12. Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
  13. COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
  14. High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathway
  15. SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling
  16. Rutin–chitooligosaccharide complex: Comprehensive evaluation of its anti-inflammatory and analgesic properties in vitro and in vivo
  17. Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
  18. Calcium-sensing receptors promoted Homer1 expression and osteogenic differentiation in bone marrow mesenchymal stem cells
  19. ABI3BP can inhibit the proliferation, invasion, and epithelial–mesenchymal transition of non-small-cell lung cancer cells
  20. Changes in blood glucose and metabolism in hyperuricemia mice
  21. Rapid detection of the GJB2 c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick
  22. IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts
  23. Short-chain fatty acid attenuates intestinal inflammation by regulation of gut microbial composition in antibiotic-associated diarrhea
  24. Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia
  25. NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
  26. Phytol-mixed micelles alleviate dexamethasone-induced osteoporosis in zebrafish: Activation of the MMP3–OPN–MAPK pathway-mediating bone remodeling
  27. Association between TGF-β1 and β-catenin expression in the vaginal wall of patients with pelvic organ prolapse
  28. Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review
  29. Effects of de novo donor-specific Class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study
  30. Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
  31. Ephedra fragilis plant extract: A groundbreaking corrosion inhibitor for mild steel in acidic environments – electrochemical, EDX, DFT, and Monte Carlo studies
  32. Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report
  33. Inhibition of mast cell activation by Jaranol-targeted Pirin ameliorates allergic responses in mouse allergic rhinitis
  34. Aeromonas veronii-induced septic arthritis of the hip in a child with acute lymphoblastic leukemia
  35. Clusterin activates the heat shock response via the PI3K/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis
  36. Research progress on fecal microbiota transplantation in tumor prevention and treatment
  37. Low-pressure exposure influences the development of HAPE
  38. Stigmasterol alleviates endplate chondrocyte degeneration through inducing mitophagy by enhancing PINK1 mRNA acetylation via the ESR1/NAT10 axis
  39. AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
  40. Association between PAX9 or MSX1 gene polymorphism and tooth agenesis risk: A meta-analysis
  41. A case of bloodstream infection caused by Neisseria gonorrhoeae
  42. Case of nasopharyngeal tuberculosis complicated with cervical lymph node and pulmonary tuberculosis
  43. p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
  44. GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway
  45. Transfer RNA-derived fragment tRF-36 modulates varicose vein progression via human vascular smooth muscle cell Notch signaling
  46. RTA-408 attenuates the hepatic ischemia reperfusion injury in mice possibly by activating the Nrf2/HO-1 signaling pathway
  47. Decreased serum TIMP4 levels in patients with rheumatoid arthritis
  48. Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells
  49. Sodium butyrate aids brain injury repair in neonatal rats
  50. Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer
  51. Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway
  52. The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
  53. Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  54. Small cell lung cancer with small intestinal metastasis: Case report and literature review
  55. GRB14: A prognostic biomarker driving tumor progression in gastric cancer through the PI3K/AKT signaling pathway by interacting with COBLL1
  56. 15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
  57. FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
  58. Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
  59. Zinc valproic acid complex promotes osteoblast differentiation and exhibits anti-osteoporotic potential
  60. Primary pulmonary synovial sarcoma in the bronchial cavity: A case report
  61. Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
  62. Uterine tumor resembling ovarian sex cord tumor with extensive rhabdoid differentiation: A case report
  63. Genomic analysis of a novel ST11(PR34365) Clostridioides difficile strain isolated from the human fecal of a CDI patient in Guizhou, China
  64. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease
  65. Changes in T-lymphocyte subpopulations in patients with colorectal cancer before and after acupoint catgut embedding acupuncture observation
  66. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
  67. Alterations of metabolites related to microbiota–gut–brain axis in plasma of colon cancer, esophageal cancer, stomach cancer, and lung cancer patients
  68. Research on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors
  69. CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway
  70. Oncolytic bacteria: A revolutionary approach to cancer therapy
  71. A de novo meningioma with rapid growth: A possible malignancy imposter?
  72. Diagnosis of secondary tuberculosis infection in an asymptomatic elderly with cancer using next-generation sequencing: Case report
  73. Hesperidin and its zinc(ii) complex enhance osteoblast differentiation and bone formation: In vitro and in vivo evaluations
  74. Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
  75. Anti-arthritic, immunomodulatory, and inflammatory regulation by the benzimidazole derivative BMZ-AD: Insights from an FCA-induced rat model
  76. Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
  77. The role of HDAC11 in age-related hearing loss: Mechanisms and therapeutic implications
  78. Evaluation and application analysis of animal models of PIPNP based on data mining
  79. Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
  80. Fabrication of zinc oxide nanoparticles using Ruellia tuberosa leaf extract induces apoptosis through P53 and STAT3 signalling pathways in prostate cancer cells
  81. Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
  82. Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
  83. The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
  84. Innovations in MALDI-TOF Mass Spectrometry: Bridging modern diagnostics and historical insights
  85. BAP1 complexes with YY1 and RBBP7 and its downstream targets in ccRCC cells
  86. Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases
  87. Electroacupuncture alleviates sciatic nerve injury in sciatica rats by regulating BDNF and NGF levels, myelin sheath degradation, and autophagy
  88. Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
  89. RNF144A and RNF144B: Important molecules for health
  90. Analysis of the detection rate and related factors of thyroid nodules in the healthy population
  91. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1
  92. Endovascular management of post-pancreatectomy hemorrhage caused by a hepatic artery pseudoaneurysm: Case report and review of the literature
  93. Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis
  94. SATB2 promotes humeral fracture healing in rats by activating the PI3K/AKT pathway
  95. Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
  96. Understanding risk factors and prognosis in diabetic foot ulcers
  97. Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
  98. FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
  99. Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11
  100. Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
  101. Cadmium toxicity, health risk and its remediation using low-cost biochar adsorbents
  102. Pulmonary cryptococcosis with headache as the first presentation: A case report
  103. Solitary pulmonary metastasis with cystic airspaces in colon cancer: A rare case report
  104. RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization
  105. Morphometric analysis and immunobiological investigation of Indigofera oblongifolia on the infected lung with Plasmodium chabaudi
  106. The NuA4/TIP60 histone-modifying complex and Hr78 modulate the Lobe2 mutant eye phenotype
  107. Experimental study on salmon demineralized bone matrix loaded with recombinant human bone morphogenetic protein-2: In vitro and in vivo study
  108. A case of IgA nephropathy treated with a combination of telitacicept and half-dose glucocorticoids
  109. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
  110. Wound healing and signaling pathways
  111. Combination of immunotherapy and whole-brain radiotherapy on prognosis of patients with multiple brain metastases: A retrospective cohort study
  112. To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
  113. Research progress on the impact of curcumin on immune responses in breast cancer
  114. Biogenic Cu/Ni nanotherapeutics from Descurainia sophia (L.) Webb ex Prantl seeds for the treatment of lung cancer
  115. Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
  116. Glycitein alleviates inflammation and apoptosis in keratinocytes via ROS-associated PI3K–Akt signalling pathway
  117. ADH5 inhibits proliferation but promotes EMT in non-small cell lung cancer cell through activating Smad2/Smad3
  118. Apoptotic efficacies of AgNPs formulated by Syzygium aromaticum leaf extract on 32D-FLT3-ITD human leukemia cell line with PI3K/AKT/mTOR signaling pathway
  119. Novel cuproptosis-related genes C1QBP and PFKP identified as prognostic and therapeutic targets in lung adenocarcinoma
  120. Bee venom promotes exosome secretion and alters miRNA cargo in T cells
  121. Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
  122. Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
  123. Kynurenine facilitates renal cell carcinoma progression by suppressing M2 macrophage pyroptosis through inhibition of CASP1 cleavage
  124. RFX5 promotes the growth, motility, and inhibits apoptosis of gastric adenocarcinoma cells through the SIRT1/AMPK axis
  125. ALKBH5 exacerbates early cardiac damage after radiotherapy for breast cancer via m6A demethylation of TLR4
  126. Phytochemicals of Roman chamomile: Antioxidant, anti-aging, and whitening activities of distillation residues
  127. Circadian gene Cry1 inhibits the tumorigenicity of hepatocellular carcinoma by the BAX/BCL2-mediated apoptosis pathway
  128. The TNFR-RIPK1/RIPK3 signalling pathway mediates the effect of lanthanum on necroptosis of nerve cells
  129. Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery
  130. The potential role of rutin, a flavonoid, in the management of cancer through modulation of cell signaling pathways
  131. Construction of pectinase gene engineering microbe and its application in tobacco sheets
  132. Construction of a microbial abundance prognostic scoring model based on intratumoral microbial data for predicting the prognosis of lung squamous cell carcinoma
  133. Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant Staphylococcus aureus and human herpesvirus 8 in an immunocompromised elderly patient: A case report
  134. Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
  135. Advances in cancer immunotherapy and future directions in personalized medicine
  136. Can coronavirus disease 2019 affect male fertility or cause spontaneous abortion? A two-sample Mendelian randomization analysis
  137. Heat stroke associated with novel leukaemia inhibitory factor receptor gene variant in a Chinese infant
  138. PSME2 exacerbates ulcerative colitis by disrupting intestinal barrier function and promoting autophagy-dependent inflammation
  139. Hyperosmolar hyperglycemic state with severe hypernatremia coexisting with central diabetes insipidus: A case report and literature review
  140. Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice
  141. Merkel cell carcinoma: Clinicopathological analysis of three patients and literature review
  142. Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population
  143. Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
  144. High levels of EPHB2 expression predict a poor prognosis and promote tumor progression in endometrial cancer
  145. Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
  146. Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
  147. Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
  148. Ecology and Environmental Science
  149. Optimization and comparative study of Bacillus consortia for cellulolytic potential and cellulase enzyme activity
  150. The complete mitochondrial genome analysis of Haemaphysalis hystricis Supino, 1897 (Ixodida: Ixodidae) and its phylogenetic implications
  151. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
  152. Indices of human impacts on landscapes: How do they reflect the proportions of natural habitats?
  153. Genetic analysis of the Siberian flying squirrel population in the northern Changbai Mountains, Northeast China: Insights into population status and conservation
  154. Diversity and environmental drivers of Suillus communities in Pinus sylvestris var. mongolica forests of Inner Mongolia
  155. Global assessment of the fate of nitrogen deposition in forest ecosystems: Insights from 15N tracer studies
  156. Fungal and bacterial pathogenic co-infections mainly lead to the assembly of microbial community in tobacco stems
  157. Influencing of coal industry related airborne particulate matter on ocular surface tear film injury and inflammatory factor expression in Sprague-Dawley rats
  158. Temperature-dependent development, predation, and life table of Sphaerophoria macrogaster (Thomson) (Diptera: Syrphidae) feeding on Myzus persicae (Sulzer) (Homoptera: Aphididae)
  159. Eleonora’s falcon trophic interactions with insects within its breeding range: A systematic review
  160. Agriculture
  161. Integrated analysis of transcriptome, sRNAome, and degradome involved in the drought-response of maize Zhengdan958
  162. Variation in flower frost tolerance among seven apple cultivars and transcriptome response patterns in two contrastingly frost-tolerant selected cultivars
  163. Heritability of durable resistance to stripe rust in bread wheat (Triticum aestivum L.)
  164. Molecular mechanism of follicular development in laying hens based on the regulation of water metabolism
  165. Animal Science
  166. Effect of sex ratio on the life history traits of an important invasive species, Spodoptera frugiperda
  167. Plant Sciences
  168. Hairpin in a haystack: In silico identification and characterization of plant-conserved microRNA in Rafflesiaceae
  169. Widely targeted metabolomics of different tissues in Rubus corchorifolius
  170. The complete chloroplast genome of Gerbera piloselloides (L.) Cass., 1820 (Carduoideae, Asteraceae) and its phylogenetic analysis
  171. Field trial to correlate mineral solubilization activity of Pseudomonas aeruginosa and biochemical content of groundnut plants
  172. Correlation analysis between semen routine parameters and sperm DNA fragmentation index in patients with semen non-liquefaction: A retrospective study
  173. Plasticity of the anatomical traits of Rhododendron L. (Ericaceae) leaves and its implications in adaptation to the plateau environment
  174. Effects of Piriformospora indica and arbuscular mycorrhizal fungus on growth and physiology of Moringa oleifera under low-temperature stress
  175. Effects of different sources of potassium fertiliser on yield, fruit quality and nutrient absorption in “Harward” kiwifruit (Actinidia deliciosa)
  176. Comparative efficiency and residue levels of spraying programs against powdery mildew in grape varieties
  177. The DREB7 transcription factor enhances salt tolerance in soybean plants under salt stress
  178. Using plant electrical signals of water hyacinth (Eichhornia crassipes) for water pollution monitoring
  179. Food Science
  180. Phytochemical analysis of Stachys iva: Discovering the optimal extract conditions and its bioactive compounds
  181. Review on role of honey in disease prevention and treatment through modulation of biological activities
  182. Computational analysis of polymorphic residues in maltose and maltotriose transporters of a wild Saccharomyces cerevisiae strain
  183. Optimization of phenolic compound extraction from Tunisian squash by-products: A sustainable approach for antioxidant and antibacterial applications
  184. Liupao tea aqueous extract alleviates dextran sulfate sodium-induced ulcerative colitis in rats by modulating the gut microbiota
  185. Toxicological qualities and detoxification trends of fruit by-products for valorization: A review
  186. Polyphenolic spectrum of cornelian cherry fruits and their health-promoting effect
  187. Optimizing the encapsulation of the refined extract of squash peels for functional food applications: A sustainable approach to reduce food waste
  188. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
  189. Impact of saline sprouting on antioxidant properties and bioactive compounds in chia seeds
  190. The dilemma of food genetics and improvement
  191. Bioengineering and Biotechnology
  192. Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
  193. Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades
  194. Application of CRISPR/Cas gene editing for infectious disease control in poultry
  195. Preparation of hafnium nitride-coated titanium implants by magnetron sputtering technology and evaluation of their antibacterial properties and biocompatibility
  196. Preparation and characterization of lemongrass oil nanoemulsion: Antimicrobial, antibiofilm, antioxidant, and anticancer activities
  197. Corrigendum
  198. Corrigendum to “Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells”
  199. Corrigendum to “Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  200. Retraction
  201. Retraction of “Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer”
Downloaded on 12.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2025-1190/html
Scroll to top button